Free preview
LAQ Comprehensive
MD Pharmacology NMC syllabus Full notes Recent advances last updated on 2026-06-19

Hypothalamic & Pituitary Drugs

ADH/Vasopressin, GnRH Analogues, Acromegaly, Prolactin Inhibitors & Gonadotropins — Mechanisms, Uses & Recent Advances

Past RGUHS + MPMSU + MUHS · 31 RGUHSSep '25 RGUHSDec '23 RGUHSJul '23 MPMSUJun '23 MUHSWinter '23 MUHSSummer '23 MPMSU2022 RGUHSJul '21 RGUHSJun '20 MUHSWinter '20 RGUHSMay '19 MUHSSummer '19 RGUHSMay '18 RGUHSMay '18 MPMSU2018 MUHSSummer '18 MPMSU2015 MPMSU2015 MPMSU2015 MUHSSummer '15 MUHSWinter '15 MUHSWinter '15 MPMSU2014 MUHSWinter '14 MPMSU2012 RGUHSMay '11 RGUHSMay '10 RGUHSMay '09 RGUHSOct '08 RGUHSApr '07 RGUHSApr '06

Hypothalamic & Pituitary Drugs

1. Definition, scope & organising principles

  • The control of metabolism, growth, and reproduction is mediated by an integrated neuroendocrine unit comprising the hypothalamus and pituitary gland; drugs in this class either mimic, replace, or block hypothalamic/pituitary hormones (Katzung 16e Ch.37, pp.703–4).
  • The pituitary (~0.6 g) sits in the sella turcica at the base of the brain, adjacent to the optic chiasm and cavernous sinuses — anatomical proximity explaining the bitemporal visual-field defects and headaches seen with pituitary macroadenomas (Katzung 16e Ch.37, p.703).
  • Two functional lobes (G&G 14e Ch.46, pp.923–4; KDT 8e Ch.17, pp.257):
    • Anterior lobe (adenohypophysis) — the "master endocrine gland"; secretes peptide trophic hormones into the systemic circulation under the control of hypothalamic releasing/inhibiting hormones delivered via the hypothalamic-adenohypophyseal portal venous system.
    • Posterior lobe (neurohypophysis)not a true gland but the axon terminals of magnocellular hypothalamic neurons (supraoptic [SON] + paraventricular [PVN] nuclei); stores and releases oxytocin and arginine vasopressin (AVP/ADH) directly into the systemic circulation, bypassing any intermediate pituitary signal.
  • Axis architecture — hypothalamic releasing hormone → amplified by anterior pituitary trophic hormone → regulated response from a target endocrine organ → target-organ hormone exerts negative feedback on both hypothalamus and pituitary (the feed-forward/feedback loop that permits precise homeostatic regulation) (G&G 14e Ch.46, pp.923–4).
  • Pharmacologic applications fall into three areas (Katzung 16e Ch.37, p.704):
    • Replacement of a deficient hormone (e.g. somatropin for GH deficiency, desmopressin for central DI).
    • Antagonism of an over-produced hormone (e.g. somatostatin analogues / pegvisomant in acromegaly, dopamine agonists in hyperprolactinaemia, vaptans in SIADH).
    • Diagnostic testing (e.g. GnRH/leuprolide test for precocious puberty, oxytocin challenge test, vasopressin/renal-concentration test).
Continue reading

Hypothalamic Pituitary Drugs

PharmaNotes Pro · Comprehensive

Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.